DT Investment Partners LLC Buys 143 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

DT Investment Partners LLC increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.8% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 3,918 shares of the healthcare conglomerate’s stock after acquiring an additional 143 shares during the quarter. DT Investment Partners LLC’s holdings in UnitedHealth Group were worth $2,291,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of UNH. Kathleen S. Wright Associates Inc. acquired a new stake in UnitedHealth Group during the 3rd quarter worth approximately $27,000. Macroview Investment Management LLC boosted its position in shares of UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after acquiring an additional 47 shares during the period. Delos Wealth Advisors LLC increased its position in UnitedHealth Group by 757.1% during the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after acquiring an additional 53 shares during the period. Bbjs Financial Advisors LLC bought a new stake in UnitedHealth Group in the 2nd quarter valued at about $31,000. Finally, Global Wealth Strategies & Associates increased its holdings in shares of UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 32 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Down 0.7 %

Shares of NYSE UNH opened at $560.82 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $608.63. The company has a 50 day simple moving average of $584.16 and a 200 day simple moving average of $536.49. The firm has a market cap of $517.87 billion, a PE ratio of 36.54, a price-to-earnings-growth ratio of 1.67 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter in the previous year, the firm posted $6.56 earnings per share. UnitedHealth Group’s revenue for the quarter was up 9.2% on a year-over-year basis. On average, research analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were issued a dividend of $2.10 per share. The ex-dividend date was Monday, September 16th. This represents a $8.40 annualized dividend and a yield of 1.50%. UnitedHealth Group’s payout ratio is 54.72%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the company. Barclays reduced their price target on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a research report on Tuesday. Hsbc Global Res downgraded UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 17th. Stephens reduced their price objective on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. Argus upped their price target on shares of UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. Finally, Wells Fargo & Company boosted their price objective on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $615.53.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.